[{"AccountsPayableCurrent_0_Q1_USD":6596000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":386909000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":12000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":271000.0,"AssetsFairValueDisclosure_0_Q1_USD":410656000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5098000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":330000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":2076000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1933000.0,"LiabilitiesFairValueDisclosure_0_Q1_USD":1628000.0,"AssetRetirementObligationsNoncurrent_0_Q1_USD":254000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":49.53,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":3445000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":387168000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1628000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":40941000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":1022000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q1_USD":-28000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":88000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":52006000.0,"EarningsPerShareDiluted_1_Q1_USD":0.65,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q1_USD":58637000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2306000.0,"DeferredTaxAssetsLiabilitiesNetNoncurrent_0_Q1_USD":10656000.0,"DeferredIncomeTaxesAndTaxCredits_1_Q1_USD":657000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":88000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":13531000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5098000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":304672000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":346227000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-23672000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1131000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":52570000.0,"RestrictedStockValueSharesIssuedNetOfTaxWithholdings_1_Q1_USD":-1140000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":608000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":80748000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":117461000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1140000.0,"OtherNoncashIncomeExpense_1_Q1_USD":2000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.065,"OperatingLeaseRightOfUseAsset_0_Q1_USD":7762000.0,"OperatingLeasePayments_1_Q1_USD":736000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":5987000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":28166000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3132000.0,"OperatingLeaseCost_1_Q1_USD":663000.0,"LiabilityForUncertainTaxPositionsNoncurrent_0_Q1_USD":1679000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":608000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":964000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":2713000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3457000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":2786000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":608000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":519000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":10083000.0,"LeaseCost_1_Q1_USD":1142000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":-67000.0,"OperatingLeaseLiability_0_Q1_USD":9119000.0,"UnrecognizedTaxBenefits_0_Q1_USD":1679000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":405000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":19751000.0,"ProfitLoss_1_Q1_USD":13443000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14153000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":488000.0,"NetIncomeLoss_1_Q1_USD":13443000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":12363000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-37201000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1166000.0,"LiabilitiesCurrent_0_Q1_USD":19139000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":510974000.0,"Liabilities_0_Q1_USD":28687000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1146000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1257000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":10407000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-179000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":14947000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":6921000.0,"CostsAndExpenses_1_Q1_USD":39699000.0,"CommonStockValue_0_Q1_USD":198000.0,"CommonStockSharesOutstanding_0_Q1_shares":19810000.0,"CommonStockSharesIssued_0_Q1_shares":19810000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":27558000.0,"AssetsCurrent_0_Q1_USD":440508000.0,"Assets_0_Q1_USD":510974000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1896000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":234000.0,"AccountsReceivableNetCurrent_0_Q1_USD":52570000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1504000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-5989000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":177183000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":9411000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_1_Q1_USD":75.36,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q1_USD":58637000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":577000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1_Q1_shares":23000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":38.28,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2002000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q1_USD":51630000.0,"OtherAssetsNoncurrent_0_Q1_USD":92000.0,"NonoperatingIncomeExpense_1_Q1_USD":2076000.0,"EarningsPerShareBasic_1_Q1_USD":0.68,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":216000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":63.32,"StockholdersEquity_0_Q1_USD":482287000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":30.16,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":3445000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":921000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":20773000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2306000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":76000.0,"ShareBasedCompensation_1_Q1_USD":5098000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":32778000.0,"OperatingIncomeLoss_1_Q1_USD":12871000.0,"DepreciationAndAmortization_1_Q1_USD":904000.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":49.53,"VariableLeaseCost_1_Q1_USD":479000.0,"Ticker":"ENTA","CIK":"1177648","name":"ENANTA PHARMACEUTICALS INC","OfficialName":"Enanta Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20191231","fy":"2020.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1492537180.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"nan","filed":"20200210"}]